Comment on: Treatment‐induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider

2021 ◽  
Author(s):  
Wing H. Tong
Keyword(s):  
Risk Factors ◽  
Venous Thrombosis ◽  
Cerebral Sinus Venous Thrombosis ◽  
Cerebral Sinus ◽  
Sinus Venous Thrombosis

Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management

2017 ◽  
Vol 64 (12) ◽  
pp. e26694 ◽  
Author(s):  
Khaled M. Ghanem ◽  
Raghida M. Dhayni ◽  
Carol Al-Aridi ◽  
Nidale Tarek ◽  
Hani Tamim ◽  
...  
Keyword(s):  
Risk Factors ◽  
Acute Lymphoblastic Leukemia ◽  
Venous Thrombosis ◽  
Lymphoblastic Leukemia ◽  
Childhood Acute Lymphoblastic Leukemia ◽  
Cerebral Sinus Venous Thrombosis ◽  
Cerebral Sinus ◽  
Sinus Venous Thrombosis

Cerebral Sinus Venous Thrombosis and Prothrombotic Risk Factors in Children

2018 ◽  
Vol 40 (6) ◽  
pp. e369-e372 ◽  
Author(s):  
Alper Ozcan ◽  
Mehmet Canpolat ◽  
Selim Doganay ◽  
Ekrem Unal ◽  
Musa Karakukcu ◽  
...  
Keyword(s):  
Risk Factors ◽  
Venous Thrombosis ◽  
Cerebral Sinus Venous Thrombosis ◽  
Prothrombotic Risk Factors ◽  
Cerebral Sinus ◽  
Sinus Venous Thrombosis

Treatment‐induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider

2021 ◽  
Author(s):  
Habib El‐Khoury ◽  
Omran Saifi ◽  
Salame Haddad ◽  
Mohamad Chahrour ◽  
Khaled M. Ghanem ◽  
...  
Keyword(s):  
Risk Factors ◽  
Venous Thrombosis ◽  
Cerebral Sinus Venous Thrombosis ◽  
Cerebral Sinus ◽  
Sinus Venous Thrombosis

Risk factors, clinical profile, and long-term outcome of 428 patients of cerebral sinus venous thrombosis: Insights from Nizam′s Institute Venous Stroke Registry, Hyderabad (India)

2012 ◽  
Vol 60 (2) ◽  
pp. 154 ◽  
Author(s):  
Subhash Kaul ◽  
AK Meena ◽  
KRukmini Mridula ◽  
Deekshanti Narayan ◽  
K Ravishankar ◽  
...  
Keyword(s):  
Risk Factors ◽  
Venous Thrombosis ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Stroke Registry ◽  
Cerebral Sinus Venous Thrombosis ◽  
Cerebral Sinus ◽  
Sinus Venous Thrombosis ◽  
Venous Stroke

scholarly journals Cerebral sinus venous thrombosis

2016 ◽  
Vol 5 (1) ◽  
pp. 177
Author(s):  
Sandhya Manorenj ◽  
Sudhaker Barla
Keyword(s):  
Risk Factors ◽  
Risk Factor ◽  
Venous Thrombosis ◽  
Protein S ◽  
Brain Parenchyma ◽  
Protein S Deficiency ◽  
S Deficiency ◽  
Cerebral Sinus Venous Thrombosis ◽  
Cerebral Sinus ◽  
Sinus Venous Thrombosis

Background: Intracranial Sino venous occlusive disease is an infrequent condition and accounts only 0.5-1% of all strokes. Objective of the study was to know the prevalence, pattern and risk factors involved in patients of cerebral sinus venous thrombosis (CSVT).Methods: Hospital databases were searched retrospectively and patients diagnosed with CSVT from December 2014 to February 2016 were identified. Data on clinical presentation, risk factor, cerebral sinus involved, hospital stay and outcome were analyzed.Results: Fifteen patients (3.4%) were identified as CSVT out of a total acute stroke case of 430. Mean age of patients was 31 years and 11 (73.3%) were males. The presenting symptoms included headache (n=14), altered sensorium (n=1) and seizures (n=5); signs included hemi paresis (n=4), papilledema (n=8) and bilateral VI nerve palsy (n=3). Majority had aseptic CSVT (n=14), and one patient had septic CSVT associated with tuberculous meningitis (TBM). Radiological findings included brain parenchyma involvement (n=8), subdural hematoma (SDH) (n=1), subarachnoid haemorrhage (SAH) (n=1) and normal brain parenchyma (n=5). Multiple cerebral sinuses were involved in seven patients. Most common site of CSVT was observed in sigmoid sinus. Risk factors included hyperhomocystenemia (n=3), protein S deficiency (n=8), protein C deficiency (n=6) and antithrombin III deficiency (n=3) as primary hypercoagulable state. ANA positive was observed in one patient and four had history of alcohol use. All fifteen patients received low molecular weight heparin (LMWH) for 1 week along with bridging oral anticoagulant. None of the patients required intrasinus thrombolysis and decompression surgery. Average hospital stay was 9 days. All had modified Rankin scale (MRS) ≤ 2 at 6 months follow up.Conclusions: Prevalence of CSVT is higher than that reported from Asian studies. Younger age and male predominance was observed. Protein S deficiency was the major risk factor for CSVT.

Cerebral sinus venous thrombosis in children

2004 ◽  
Vol 40 (1-2) ◽  
pp. 53-55 ◽  
Author(s):  
C Barnes ◽  
F Newall ◽  
J Furmedge ◽  
M Mackay ◽  
P Monagle
Keyword(s):  
Venous Thrombosis ◽  
Cerebral Sinus Venous Thrombosis ◽  
Cerebral Sinus ◽  
Sinus Venous Thrombosis
Sign in / Sign up

Export Citation Format

Share Document